FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122022191> ?p ?o ?g. }

• W2122022191 endingPage "140" @default.
• W2122022191 startingPage "137" @default.
• W2122022191 abstract "A few patients remain severely affected by atopic dermatitis into adult life despite treatment with systemic steroids, azathioprine, and photochemotherapy. 33 patients took part in a double-blind, placebo-controlled, crossover study to assess the efficacy and safety of cyclosporin (5 mg/kg per day) in adults with severe refractory atopic dermatitis. Treatments were given for eight weeks each with one group (n = 16) receiving placebo followed by cyclosporin and another (n = 17) receiving cyclosporin and then placebo. Disease activity, extent of disease, sleep and itch, topical steroid use, and adverse events were assessed every two weeks. Both extent and activity of dermatitis were significantly improved (p less than 0.001) as were subjective measures of disease. 20 patients receiving cyclosporin reported adverse events compared with 8 taking placebo, although no patient required withdrawal from the study. Cyclosporin therapy led to an increase in the mean serum urea, creatinine, and bilirubin concentrations, although only the rise in bilirubin was significant (p = 0.001). Our results confirm that cyclosporin is a safe and effective short-term treatment for severe, refractory atopic dermatitis." @default.
• W2122022191 created "2016-06-24" @default.
• W2122022191 creator A5021497432 @default.
• W2122022191 creator A5035743516 @default.
• W2122022191 creator A5038182570 @default.
• W2122022191 creator A5055488236 @default.
• W2122022191 creator A5057216508 @default.
• W2122022191 creator A5059679568 @default.
• W2122022191 creator A5077974055 @default.
• W2122022191 creator A5081147172 @default.
• W2122022191 creator A5089384246 @default.
• W2122022191 creator A5025895718 @default.
• W2122022191 date "1991-07-01" @default.
• W2122022191 modified "2023-09-30" @default.
• W2122022191 title "Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis" @default.
• W2122022191 cites W156305783 @default.
• W2122022191 cites W1966946167 @default.
• W2122022191 cites W2003142784 @default.
• W2122022191 cites W2016811833 @default.
• W2122022191 cites W2019194645 @default.
• W2122022191 cites W2051612462 @default.
• W2122022191 cites W2066752294 @default.
• W2122022191 cites W2092571798 @default.
• W2122022191 cites W2115710949 @default.
• W2122022191 cites W4251850870 @default.
• W2122022191 doi "https://doi.org/10.1016/0140-6736(91)90134-b" @default.
• W2122022191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1677063" @default.
• W2122022191 hasPublicationYear "1991" @default.
• W2122022191 type Work @default.
• W2122022191 sameAs 2122022191 @default.
• W2122022191 citedByCount "392" @default.
• W2122022191 countsByYear W21220221912012 @default.
• W2122022191 countsByYear W21220221912013 @default.
• W2122022191 countsByYear W21220221912014 @default.
• W2122022191 countsByYear W21220221912015 @default.
• W2122022191 countsByYear W21220221912016 @default.
• W2122022191 countsByYear W21220221912017 @default.
• W2122022191 countsByYear W21220221912018 @default.
• W2122022191 countsByYear W21220221912019 @default.
• W2122022191 countsByYear W21220221912020 @default.
• W2122022191 countsByYear W21220221912021 @default.
• W2122022191 countsByYear W21220221912022 @default.
• W2122022191 countsByYear W21220221912023 @default.
• W2122022191 crossrefType "journal-article" @default.
• W2122022191 hasAuthorship W2122022191A5021497432 @default.
• W2122022191 hasAuthorship W2122022191A5025895718 @default.
• W2122022191 hasAuthorship W2122022191A5035743516 @default.
• W2122022191 hasAuthorship W2122022191A5038182570 @default.
• W2122022191 hasAuthorship W2122022191A5055488236 @default.
• W2122022191 hasAuthorship W2122022191A5057216508 @default.
• W2122022191 hasAuthorship W2122022191A5059679568 @default.
• W2122022191 hasAuthorship W2122022191A5077974055 @default.
• W2122022191 hasAuthorship W2122022191A5081147172 @default.
• W2122022191 hasAuthorship W2122022191A5089384246 @default.
• W2122022191 hasConcept C121332964 @default.
• W2122022191 hasConcept C126322002 @default.
• W2122022191 hasConcept C142424586 @default.
• W2122022191 hasConcept C142724271 @default.
• W2122022191 hasConcept C16005928 @default.
• W2122022191 hasConcept C197934379 @default.
• W2122022191 hasConcept C204787440 @default.
• W2122022191 hasConcept C27081682 @default.
• W2122022191 hasConcept C2776694085 @default.
• W2122022191 hasConcept C2776760755 @default.
• W2122022191 hasConcept C2777513400 @default.
• W2122022191 hasConcept C2778329239 @default.
• W2122022191 hasConcept C2779134260 @default.
• W2122022191 hasConcept C2779528694 @default.
• W2122022191 hasConcept C2780306776 @default.
• W2122022191 hasConcept C71924100 @default.
• W2122022191 hasConcept C87355193 @default.
• W2122022191 hasConcept C87813604 @default.
• W2122022191 hasConcept C90924648 @default.
• W2122022191 hasConceptScore W2122022191C121332964 @default.
• W2122022191 hasConceptScore W2122022191C126322002 @default.
• W2122022191 hasConceptScore W2122022191C142424586 @default.
• W2122022191 hasConceptScore W2122022191C142724271 @default.
• W2122022191 hasConceptScore W2122022191C16005928 @default.
• W2122022191 hasConceptScore W2122022191C197934379 @default.
• W2122022191 hasConceptScore W2122022191C204787440 @default.
• W2122022191 hasConceptScore W2122022191C27081682 @default.
• W2122022191 hasConceptScore W2122022191C2776694085 @default.
• W2122022191 hasConceptScore W2122022191C2776760755 @default.
• W2122022191 hasConceptScore W2122022191C2777513400 @default.
• W2122022191 hasConceptScore W2122022191C2778329239 @default.
• W2122022191 hasConceptScore W2122022191C2779134260 @default.
• W2122022191 hasConceptScore W2122022191C2779528694 @default.
• W2122022191 hasConceptScore W2122022191C2780306776 @default.
• W2122022191 hasConceptScore W2122022191C71924100 @default.
• W2122022191 hasConceptScore W2122022191C87355193 @default.
• W2122022191 hasConceptScore W2122022191C87813604 @default.
• W2122022191 hasConceptScore W2122022191C90924648 @default.
• W2122022191 hasIssue "8760" @default.
• W2122022191 hasLocation W21220221911 @default.
• W2122022191 hasLocation W21220221912 @default.
• W2122022191 hasOpenAccess W2122022191 @default.
• W2122022191 hasPrimaryLocation W21220221911 @default.
• W2122022191 hasRelatedWork W1860721670 @default.

• next